Reversed functional organization of mouse and human APOBEC3 cytidine deaminase domains
- PMID:17020885
- DOI: 10.1074/jbc.M604980200
Reversed functional organization of mouse and human APOBEC3 cytidine deaminase domains
Abstract
APOBEC3 proteins comprise a multigene family of antiviral cytidine deaminases that are active against human immunodeficiency virus, simian immunodeficiency virus, endogenous retroelements. The Vif protein of lentiviruses binds to specific APOBEC3 proteins, notably A3F and A3G, to induce their degradation by proteasomes. APOBEC3 proteins are of two types, those with a single deaminase domain such as human (h)A3A and hA3C and those with two cytidine deaminase domains (CDD) such as hA3G, hA3F, hA3B and the mouse APOBEC3, mA3. In hA3G, both active sites are required for antiviral function but serve separate functions. CDD2 mediates the C to U deamination of the human immunodeficiency virus type 1 genome, whereas CDD1 binds the viral RNA to allow for virion packaging. Here we analyzed the role of the two domains in additional APOBEC3 family members. We analyzed APOBEC3 proteins in which either the critical glutamic acid residue or the Zn(2+) coordination amino acid residues in the active sites were mutated. The separation of function of the domains is maintained in hA3B and hA3F, but in the mouse protein mA3, the roles of the two domains are reversed. Deamination is mediated by CDD1, whereas encapsidation and dimerization are mediated by CDD2. Antiviral function of each of the APOBEC3 proteins was largely attributable to deaminase activity. Deaminase-independent antiviral activity of the active site mutants was minor. These findings suggest that the two active sites have different functions but that these functions can be interchanged in different APOBEC3 family members.
Similar articles
- Distinct determinants in HIV-1 Vif and human APOBEC3 proteins are required for the suppression of diverse host anti-viral proteins.Zhang W, Chen G, Niewiadomska AM, Xu R, Yu XF.Zhang W, et al.PLoS One. 2008;3(12):e3963. doi: 10.1371/journal.pone.0003963. Epub 2008 Dec 17.PLoS One. 2008.PMID:19088851Free PMC article.
- Species-specific restriction of apobec3-mediated hypermutation.Browne EP, Littman DR.Browne EP, et al.J Virol. 2008 Feb;82(3):1305-13. doi: 10.1128/JVI.01371-07. Epub 2007 Nov 21.J Virol. 2008.PMID:18032489Free PMC article.
- Vif Proteins from Diverse Human Immunodeficiency Virus/Simian Immunodeficiency Virus Lineages Have Distinct Binding Sites in A3C.Zhang Z, Gu Q, Jaguva Vasudevan AA, Jeyaraj M, Schmidt S, Zielonka J, Perković M, Heckel JO, Cichutek K, Häussinger D, Smits SHJ, Münk C.Zhang Z, et al.J Virol. 2016 Oct 28;90(22):10193-10208. doi: 10.1128/JVI.01497-16. Print 2016 Nov 15.J Virol. 2016.PMID:27581978Free PMC article.
- [Antiviral defense by APOBEC3 family proteins].Takaori A.Takaori A.Uirusu. 2005 Dec;55(2):267-72. doi: 10.2222/jsv.55.267.Uirusu. 2005.PMID:16557012Review.Japanese.
- Host restriction of HIV-1 by APOBEC3 and viral evasion through Vif.Niewiadomska AM, Yu XF.Niewiadomska AM, et al.Curr Top Microbiol Immunol. 2009;339:1-25. doi: 10.1007/978-3-642-02175-6_1.Curr Top Microbiol Immunol. 2009.PMID:20012521Review.
Cited by
- Nuclear Magnetic Resonance Structure of the APOBEC3B Catalytic Domain: Structural Basis for Substrate Binding and DNA Deaminase Activity.Byeon IJ, Byeon CH, Wu T, Mitra M, Singer D, Levin JG, Gronenborn AM.Byeon IJ, et al.Biochemistry. 2016 May 31;55(21):2944-59. doi: 10.1021/acs.biochem.6b00382. Epub 2016 May 19.Biochemistry. 2016.PMID:27163633Free PMC article.
- Characterization of the Catalytic Domain of Human APOBEC3B and the Critical Structural Role for a Conserved Methionine.Siriwardena SU, Guruge TA, Bhagwat AS.Siriwardena SU, et al.J Mol Biol. 2015 Sep 25;427(19):3042-55. doi: 10.1016/j.jmb.2015.08.006. Epub 2015 Aug 14.J Mol Biol. 2015.PMID:26281709Free PMC article.
- APOBECs and virus restriction.Harris RS, Dudley JP.Harris RS, et al.Virology. 2015 May;479-480:131-45. doi: 10.1016/j.virol.2015.03.012. Epub 2015 Mar 26.Virology. 2015.PMID:25818029Free PMC article.Review.
- Targeting APOBEC3A to the viral nucleoprotein complex confers antiviral activity.Goila-Gaur R, Khan MA, Miyagi E, Kao S, Strebel K.Goila-Gaur R, et al.Retrovirology. 2007 Aug 29;4:61. doi: 10.1186/1742-4690-4-61.Retrovirology. 2007.PMID:17727729Free PMC article.
- APOBEC3 multimerization correlates with HIV-1 packaging and restriction activity in living cells.Li J, Chen Y, Li M, Carpenter MA, McDougle RM, Luengas EM, Macdonald PJ, Harris RS, Mueller JD.Li J, et al.J Mol Biol. 2014 Mar 20;426(6):1296-307. doi: 10.1016/j.jmb.2013.12.014. Epub 2013 Dec 17.J Mol Biol. 2014.PMID:24361275Free PMC article.
Publication types
MeSH terms
Substances
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases